ArticleInternational journal of hematology2018

Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302).

Takayoshi Tachibana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.